相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。DNA repair and replication proteins as prognostic markers in melanoma
Liang Song et al.
HISTOPATHOLOGY (2013)
Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Survival in BRAF V600-Mutant Advanced Melanoma Treated with Vemurafenib
Jeffrey A. Sosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Orchestrating the nucleases involved in DNA interstrand cross-link (ICL) repair
Blanka Sengerova et al.
CELL CYCLE (2011)
Role of Endonucleases XPF and XPG in Nucleotide Excision Repair of Platinated DNA and Cisplatin/Oxaliplatin Cytotoxicity
Nora Graf et al.
CHEMBIOCHEM (2011)
Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair
Anderson T. Wang et al.
GENES & DEVELOPMENT (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
MicroRNA-155 targets the SKI gene in human melanoma cell lines
Lauretta Levati et al.
PIGMENT CELL & MELANOMA RESEARCH (2011)
A phase II study of oxaliplatin, docetaxel, and GM-CSF in patients with previously treated advanced melanoma
Frederick Locke et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells
Sanjeevani Arora et al.
DNA REPAIR (2010)
High expression of DNA repair pathways is associated with metastasis in melanoma patients
A. Kauffmann et al.
ONCOGENE (2008)
The ERCC1/XPF endonuclease is required for efficient single-strand annealing and gene conversion in mammalian cells
Ali Z. Al-Minawi et al.
NUCLEIC ACIDS RESEARCH (2008)
Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: A meta-analysis of 18 trials involving 2,621 patients
Natalie J. Ives et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Repression of cell cycle-related proteins by oxaliplatin but not cisplatin in human colon cancer cells
Carole Voland et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Detection of oxaliplatin-induced DNA crosslinks in vitro and in cancer patients using the alkaline comet assay
GM Almeida et al.
DNA REPAIR (2006)
Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases
F Carta et al.
MELANOMA RESEARCH (2005)
The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks
LJ Niedernhofer et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin
IU De Silva et al.
NUCLEIC ACIDS RESEARCH (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
Oxaliplatin is active in vitro against human melanoma cell lines:: comparison with cisplatin and carboplatin
MQ Mohammed et al.
ANTI-CANCER DRUGS (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
